肺动脉高压患者-话题@MedSci

#肺动脉高压患者#

103篇内容 | 2938人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1808638, encodeId=ad8918086389d, content=<a href='/topic/show?id=eade820e7c0' target=_blank style='color:#2F92EE;'>#肺动脉高压患者#</a>, objectTitle=Lancet Respir Med：西地那非与吡非尼酮对特发性纤维化相关的肺动脉高压患者中的疗效和安全性评估, objectType=article, longId=217949, objectId=9c9021e94927, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c9021e94927, replyNumber=0, likeNumber=79, createdTime=2022-03-20, rootId=0, userName=naiwu77, userId=5b0e350, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c9021e94927, moduleTitle=Lancet Respir Med：西地那非与吡非尼酮对特发性纤维化相关的肺动脉高压患者中的疗效和安全性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c9021e94927)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1808636, encodeId=afd918086364f, content=<a href='/topic/show?id=eade820e7c0' target=_blank style='color:#2F92EE;'>#肺动脉高压患者#</a>, objectTitle=Lancet Respir Med：肺动脉高压患者连续服用Selonsertib的疗效和安全性, objectType=article, longId=217067, objectId=4dc921e067d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4dc921e067d9, replyNumber=0, likeNumber=63, createdTime=2021-09-22, rootId=0, userName=naiwu77, userId=5b0e350, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4dc921e067d9, moduleTitle=Lancet Respir Med：肺动脉高压患者连续服用Selonsertib的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4dc921e067d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1808646, encodeId=1ddd180864615, content=<a href='/topic/show?id=eade820e7c0' target=_blank style='color:#2F92EE;'>#肺动脉高压患者#</a>, objectTitle=ERJ：维生素 D 缺乏症难道是肺动脉高压患者对西地那非反应不足的潜在原因？, objectType=article, longId=218496, objectId=0b4921849656, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b4921849656, replyNumber=0, likeNumber=81, createdTime=2022-07-18, rootId=0, userName=naiwu77, userId=5b0e350, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b4921849656, moduleTitle=ERJ：维生素 D 缺乏症难道是肺动脉高压患者对西地那非反应不足的潜在原因？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b4921849656)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1808632, encodeId=7ac81808632f5, content=<a href='/topic/show?id=eade820e7c0' target=_blank style='color:#2F92EE;'>#肺动脉高压患者#</a>, objectTitle=J Heart Lung Transplant：肺血管阻力指数预测肺动脉高压患者预后的性能优于肺血管阻力？, objectType=article, longId=211083, objectId=cdbe2110836e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdbe2110836e, replyNumber=0, likeNumber=72, createdTime=2021-07-10, rootId=0, userName=naiwu77, userId=5b0e350, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdbe2110836e, moduleTitle=J Heart Lung Transplant：肺血管阻力指数预测肺动脉高压患者预后的性能优于肺血管阻力？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cdbe2110836e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1808659, encodeId=753b18086597f, content=<a href='/topic/show?id=eade820e7c0' target=_blank style='color:#2F92EE;'>#肺动脉高压患者#</a>, objectTitle=β-抑制蛋白介导的血管紧张素II受体激活促进肺动脉高压患者的肺血管重塑, objectType=article, longId=221661, objectId=e9cf22166145, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9cf22166145, replyNumber=0, likeNumber=84, createdTime=2022-07-30, rootId=0, userName=naiwu77, userId=5b0e350, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9cf22166145, moduleTitle=β-抑制蛋白介导的血管紧张素II受体激活促进肺动脉高压患者的肺血管重塑, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9cf22166145)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1808656, encodeId=4765180865609, content=<a href='/topic/show?id=eade820e7c0' target=_blank style='color:#2F92EE;'>#肺动脉高压患者#</a>, objectTitle=胸部HRCT对特发性肺动脉高压患者生存的预测价值, objectType=article, longId=220650, objectId=88a9220650cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88a9220650cf, replyNumber=0, likeNumber=0, createdTime=2022-06-21, rootId=0, userName=naiwu77, userId=5b0e350, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88a9220650cf, moduleTitle=胸部HRCT对特发性肺动脉高压患者生存的预测价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88a9220650cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1808633, encodeId=66541808633f3, content=<a href='/topic/show?id=eade820e7c0' target=_blank style='color:#2F92EE;'>#肺动脉高压患者#</a>, objectTitle=Lancet Respir Med：吸入性Treprostinil可明显改善间质性肺疾病和相关肺动脉高压患者的肺活量, objectType=article, longId=213790, objectId=a278213e9097, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a278213e9097, replyNumber=0, likeNumber=80, createdTime=2022-04-29, rootId=0, userName=naiwu77, userId=5b0e350, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a278213e9097, moduleTitle=Lancet Respir Med：吸入性Treprostinil可明显改善间质性肺疾病和相关肺动脉高压患者的肺活量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a278213e9097)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1808635, encodeId=ba9d180863551, content=<a href='/topic/show?id=eade820e7c0' target=_blank style='color:#2F92EE;'>#肺动脉高压患者#</a>, objectTitle=J Heart Lung Transplant：Riociguat可改善肺动脉高压患者的右心室功能, objectType=article, longId=215681, objectId=740e215681ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=740e215681ad, replyNumber=0, likeNumber=90, createdTime=2022-06-04, rootId=0, userName=naiwu77, userId=5b0e350, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=740e215681ad, moduleTitle=J Heart Lung Transplant：Riociguat可改善肺动脉高压患者的右心室功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=740e215681ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1808660, encodeId=f5dd18086608a, content=<a href='/topic/show?id=eade820e7c0' target=_blank style='color:#2F92EE;'>#肺动脉高压患者#</a>, objectTitle=特发性肺动脉高压和先天性心脏病肺动脉高压患者血清脂质分布差异, objectType=article, longId=264990, objectId=468926499078, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=468926499078, replyNumber=0, likeNumber=90, createdTime=2022-02-10, rootId=0, userName=naiwu77, userId=5b0e350, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=468926499078, moduleTitle=特发性肺动脉高压和先天性心脏病肺动脉高压患者血清脂质分布差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=468926499078)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1808653, encodeId=163c18086531b, content=<a href='/topic/show?id=eade820e7c0' target=_blank style='color:#2F92EE;'>#肺动脉高压患者#</a>, objectTitle=红细胞颜色降低对肺动脉高压患者的预后影响, objectType=article, longId=220234, objectId=c767220234d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c767220234d9, replyNumber=0, likeNumber=70, createdTime=2022-06-26, rootId=0, userName=naiwu77, userId=5b0e350, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c767220234d9, moduleTitle=红细胞颜色降低对肺动脉高压患者的预后影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c767220234d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1808654, encodeId=dcf71808654a7, content=<a href='/topic/show?id=eade820e7c0' target=_blank style='color:#2F92EE;'>#肺动脉高压患者#</a>, objectTitle=AJRCCM：吸入曲前列环素对间质性肺病引起的肺动脉高压患者的临床研究, objectType=article, longId=220320, objectId=e2db220320c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2db220320c3, replyNumber=0, likeNumber=98, createdTime=2022-10-04, rootId=0, userName=naiwu77, userId=5b0e350, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2db220320c3, moduleTitle=AJRCCM：吸入曲前列环素对间质性肺病引起的肺动脉高压患者的临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2db220320c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1808643, encodeId=6a51180864348, content=<a href='/topic/show?id=eade820e7c0' target=_blank style='color:#2F92EE;'>#肺动脉高压患者#</a>, objectTitle=观察研究(VENTASTEP):吸入伊洛前列素治疗肺动脉高压患者的体力活动、心率和吸入行为的数字跟踪, objectType=article, longId=218348, objectId=96112183482b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96112183482b, replyNumber=0, likeNumber=66, createdTime=2022-06-08, rootId=0, userName=naiwu77, userId=5b0e350, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96112183482b, moduleTitle=观察研究(VENTASTEP):吸入伊洛前列素治疗肺动脉高压患者的体力活动、心率和吸入行为的数字跟踪, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96112183482b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1808630, encodeId=dca5180863077, content=<a href='/topic/show?id=eade820e7c0' target=_blank style='color:#2F92EE;'>#肺动脉高压患者#</a>, objectTitle=JAHA：TNFRSF13B基因c.226G>A（p.Gly76Ser）是肺动脉高压患者新型致病突变, objectType=article, longId=207190, objectId=fbff20e190b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fbff20e190b5, replyNumber=0, likeNumber=63, createdTime=2021-11-09, rootId=0, userName=naiwu77, userId=5b0e350, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fbff20e190b5, moduleTitle=JAHA：TNFRSF13B基因c.226G>A（p.Gly76Ser）是肺动脉高压患者新型致病突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fbff20e190b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1808645, encodeId=4e40180864518, content=<a href='/topic/show?id=eade820e7c0' target=_blank style='color:#2F92EE;'>#肺动脉高压患者#</a>, objectTitle=AJP：对肺动脉高压患者性别差异的病理生物学和药理学基础的新见解, objectType=article, longId=218456, objectId=76b0218456d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76b0218456d2, replyNumber=0, likeNumber=80, createdTime=2022-06-13, rootId=0, userName=naiwu77, userId=5b0e350, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76b0218456d2, moduleTitle=AJP：对肺动脉高压患者性别差异的病理生物学和药理学基础的新见解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76b0218456d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1808644, encodeId=590c1808644e7, content=<a href='/topic/show?id=eade820e7c0' target=_blank style='color:#2F92EE;'>#肺动脉高压患者#</a>, objectTitle=ERJ：轻度肺动脉高压患者RVSP升高与死亡风险增加有关, objectType=article, longId=218443, objectId=a2492184433f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2492184433f, replyNumber=0, likeNumber=98, createdTime=2022-09-07, rootId=0, userName=naiwu77, userId=5b0e350, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2492184433f, moduleTitle=ERJ：轻度肺动脉高压患者RVSP升高与死亡风险增加有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2492184433f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1808650, encodeId=6a0b18086504a, content=<a href='/topic/show?id=eade820e7c0' target=_blank style='color:#2F92EE;'>#肺动脉高压患者#</a>, objectTitle=肺动脉高压患者中支气管动脉也有病变吗？, objectType=article, longId=219144, objectId=c02c21914486, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c02c21914486, replyNumber=0, likeNumber=79, createdTime=2022-07-02, rootId=0, userName=naiwu77, userId=5b0e350, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c02c21914486, moduleTitle=肺动脉高压患者中支气管动脉也有病变吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c02c21914486)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1808639, encodeId=43811808639bc, content=<a href='/topic/show?id=eade820e7c0' target=_blank style='color:#2F92EE;'>#肺动脉高压患者#</a>, objectTitle=JCSM：羧基麦芽糖铁可有效纠正肺动脉高压患者的缺铁状态, objectType=article, longId=218056, objectId=6f9d21805631, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f9d21805631, replyNumber=0, likeNumber=95, createdTime=2022-02-05, rootId=0, userName=naiwu77, userId=5b0e350, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f9d21805631, moduleTitle=JCSM：羧基麦芽糖铁可有效纠正肺动脉高压患者的缺铁状态, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f9d21805631)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1808631, encodeId=9bea18086316d, content=<a href='/topic/show?id=eade820e7c0' target=_blank style='color:#2F92EE;'>#肺动脉高压患者#</a>, objectTitle=JAHA：肺动脉高压患者缺血性卒中预后的性别差异, objectType=article, longId=208229, objectId=6d49208229a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d49208229a0, replyNumber=0, likeNumber=84, createdTime=2021-03-28, rootId=0, userName=naiwu77, userId=5b0e350, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d49208229a0, moduleTitle=JAHA：肺动脉高压患者缺血性卒中预后的性别差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d49208229a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1808629, encodeId=e06e180862973, content=<a href='/topic/show?id=eade820e7c0' target=_blank style='color:#2F92EE;'>#肺动脉高压患者#</a>, objectTitle=Eur Respir J：CILP1作为肺动脉高压患者右室不良改变的生物标志物, objectType=article, longId=203421, objectId=1721203421a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1721203421a3, replyNumber=0, likeNumber=75, createdTime=2021-01-06, rootId=0, userName=naiwu77, userId=5b0e350, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1721203421a3, moduleTitle=Eur Respir J：CILP1作为肺动脉高压患者右室不良改变的生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1721203421a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1808627, encodeId=4b5e180862ea8, content=<a href='/topic/show?id=eade820e7c0' target=_blank style='color:#2F92EE;'>#肺动脉高压患者#</a>, objectTitle= Lancet respir med：肺动脉高压患者肺血管阻力与心血管不良预后风险, objectType=article, longId=198288, objectId=1f0419828833, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f0419828833, replyNumber=0, likeNumber=63, createdTime=2020-10-12, rootId=0, userName=naiwu77, userId=5b0e350, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f0419828833, moduleTitle= Lancet respir med：肺动脉高压患者肺血管阻力与心血管不良预后风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f0419828833)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肺动脉高压患者

2020-05-29

naiwu77 (审核中...)

前往app查看评论内容

#肺动脉高压患者#

Lancet Respir Med：西地那非与吡非尼酮对特发性纤维化相关的肺动脉高压患者中的疗效和安全性评估

2022-03-20

naiwu77 (审核中...)

前往app查看评论内容

#肺动脉高压患者#

Lancet Respir Med：肺动脉高压患者连续服用Selonsertib的疗效和安全性

2021-09-22

naiwu77 (审核中...)

前往app查看评论内容

#肺动脉高压患者#

ERJ：维生素 D 缺乏症难道是肺动脉高压患者对西地那非反应不足的潜在原因？

2022-07-18

naiwu77 (审核中...)

前往app查看评论内容

#肺动脉高压患者#

J Heart Lung Transplant：肺血管阻力指数预测肺动脉高压患者预后的性能优于肺血管阻力？

2021-07-10

naiwu77 (审核中...)

前往app查看评论内容

#肺动脉高压患者#

β-抑制蛋白介导的血管紧张素II受体激活促进肺动脉高压患者的肺血管重塑

2022-07-30

naiwu77 (审核中...)

前往app查看评论内容

#肺动脉高压患者#

胸部HRCT对特发性肺动脉高压患者生存的预测价值

2022-06-21

naiwu77 (审核中...)

前往app查看评论内容

#肺动脉高压患者#

Lancet Respir Med：吸入性Treprostinil可明显改善间质性肺疾病和相关肺动脉高压患者的肺活量

2022-04-29

naiwu77 (审核中...)

前往app查看评论内容

#肺动脉高压患者#

J Heart Lung Transplant：Riociguat可改善肺动脉高压患者的右心室功能

2022-06-04

naiwu77 (审核中...)

前往app查看评论内容

#肺动脉高压患者#

特发性肺动脉高压和先天性心脏病肺动脉高压患者血清脂质分布差异

2022-02-10

naiwu77 (审核中...)

前往app查看评论内容

#肺动脉高压患者#

红细胞颜色降低对肺动脉高压患者的预后影响

2022-06-26

naiwu77 (审核中...)

前往app查看评论内容

#肺动脉高压患者#

AJRCCM：吸入曲前列环素对间质性肺病引起的肺动脉高压患者的临床研究

2022-10-04

naiwu77 (审核中...)

前往app查看评论内容

#肺动脉高压患者#

观察研究(VENTASTEP):吸入伊洛前列素治疗肺动脉高压患者的体力活动、心率和吸入行为的数字跟踪

2022-06-08

naiwu77 (审核中...)

前往app查看评论内容

#肺动脉高压患者#

JAHA：TNFRSF13B基因c.226G>A（p.Gly76Ser）是肺动脉高压患者新型致病突变

2021-11-09

naiwu77 (审核中...)

前往app查看评论内容

#肺动脉高压患者#

AJP：对肺动脉高压患者性别差异的病理生物学和药理学基础的新见解

2022-06-13

naiwu77 (审核中...)

前往app查看评论内容

#肺动脉高压患者#

ERJ：轻度肺动脉高压患者RVSP升高与死亡风险增加有关

2022-09-07

naiwu77 (审核中...)

前往app查看评论内容

#肺动脉高压患者#

肺动脉高压患者中支气管动脉也有病变吗？

2022-07-02

naiwu77 (审核中...)

前往app查看评论内容

#肺动脉高压患者#

JCSM：羧基麦芽糖铁可有效纠正肺动脉高压患者的缺铁状态

2022-02-05

naiwu77 (审核中...)

前往app查看评论内容

#肺动脉高压患者#

JAHA：肺动脉高压患者缺血性卒中预后的性别差异

2021-03-28

naiwu77 (审核中...)

前往app查看评论内容

#肺动脉高压患者#

Eur Respir J：CILP1作为肺动脉高压患者右室不良改变的生物标志物

2021-01-06

naiwu77 (审核中...)

前往app查看评论内容

#肺动脉高压患者#

Lancet respir med：肺动脉高压患者肺血管阻力与心血管不良预后风险

2020-10-12

科室
- - 订阅+
  - 更多科室
工具
服务